We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $5.1B
1-Year Est. Return 39.13%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
AUM
$967M
AUM Growth
-$11.3M
Cap. Flow
-$111M
Cap. Flow %
-11.5%
Top 10 Hldgs %
49.41%
Holding
180
New
62
Increased
13
Reduced
11
Closed
61

Top Sells

Rank Stock Value
1
ROL icon
Rollins
ROL
+$93.3M
2
AER icon
AerCap
AER
+$81.5M
3
ENB icon
Enbridge
ENB
+$53.1M
4
JD icon
JD.com
JD
+$29.1M
5
CNM icon
Core & Main
CNM
+$28.9M

Sector Composition

Rank Sector Weight
1 Technology 28.91%
2 Consumer Discretionary 19.8%
3 Financials 13.08%
4 Energy 7.41%
5 Healthcare 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABVX
101
Abivax
ABVX
$8.92B
$642K 0.07%
+60,000
New +$612K
EPRT icon
102
Essential Properties Realty Trust
EPRT
$5.8B
$639K 0.07%
25,000
SLRN
103
DELISTED
ACELYRIN
SLRN
$522K 0.05%
70,000
DH icon
104
Definitive Healthcare
DH
$104M
$497K 0.05%
50,000
RARE icon
105
Ultragenyx Pharmaceutical
RARE
$1.27B
$478K 0.05%
+10,000
New +$388K
XENE icon
106
Xenon Pharmaceuticals
XENE
$5.5B
$461K 0.05%
+10,000
New +$353K
PLGO
107
Pelagos Insurance Capital
PLGO
$2B
$445K 0.05%
+35,125
New +$472K
CRBU icon
108
Caribou Biosciences
CRBU
$134M
$430K 0.04%
75,000
LAW icon
109
CS Disco
LAW
$273M
$380K 0.04%
50,000
DRVN icon
110
Driven Brands
DRVN
$1.99B
$357K 0.04%
25,000
SGMT icon
111
Sagimet Biosciences
SGMT
$650M
$325K 0.03%
60,000
ARQT icon
112
Arcutis Biotherapeutics
ARQT
$3.29B
$323K 0.03%
+100,000
New +$272K
NMRA icon
113
Neumora Therapeutics
NMRA
$145M
$171K 0.02%
10,000
AUGX
114
DELISTED
Augmedix, Inc. Common Stock
AUGX
$146K 0.02%
+25,000
New +$132K
PL icon
115
Planet Labs
PL
$5.84B
$98.8K 0.01%
40,000
SVIIR
116
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$16.2K ﹤0.01%
211,791
AER icon
117
AerCap
AER
$22.4B
-1,300,000
Closed -$81.5M
AMKR icon
118
Amkor Technology
AMKR
$11.5B
-53,837
Closed -$1.22M
APG icon
119
APi Group
APG
$15.9B
-119,258
Closed -$2.06M
ASO icon
120
Academy Sports + Outdoors
ASO
$3.11B
-85,800
Closed -$4.06M
BCYC
121
Bicycle Therapeutics
BCYC
$255M
-50,000
Closed -$1M
BE icon
122
Bloom Energy
BE
$79.6B
-100,000
Closed -$1.33M
BMBL icon
123
Bumble
BMBL
$397M
-200,000
Closed -$2.98M
BMEA icon
124
Biomea Fusion
BMEA
$126M
-20,000
Closed -$275K
BTE icon
125
Baytex Energy
BTE
$3.42B
-2,000,000
Closed -$8.82M

Similar funds

Ghisallo Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Ghisallo Capital Management held 180 positions worth $967M, down 1.2% from $979M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Ghisallo Capital Management withdrew a net $111M in Q4 2023, closing 61 positions and reducing 11 holdings. Its most notable exit was Rollins, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Ghisallo Capital Management opened a new position in Las Vegas Sands worth $73.8M.

  • Ghisallo Capital Management's largest Q4 2023 buy was Las Vegas Sands: 1,500,000 shares worth $73.8M.
  • Ghisallo Capital Management added most to Corebridge Financial in Q4 2023, an estimated $61.9M increase.
  • Ghisallo Capital Management's biggest Q4 2023 reduction was Enbridge, cutting an estimated $53.1M.
  • Ghisallo Capital Management fully exited Rollins in Q4 2023, selling an estimated $93.3M.
  • Ghisallo Capital Management's ten largest holdings make up 49% of its $967M portfolio in Q4 2023.
  • Ghisallo Capital Management opened 62 new positions and closed 61 in Q4 2023.
  • Ghisallo Capital Management's portfolio value fell 1.2% quarter-over-quarter to $967M.

Based on Ghisallo Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.